Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy

•BTX-A injections improve gait kinematics and kinetics in CP children.•BTX-A treatment has a limited effect on the muscle balance in CP children.•EMG-constrained optimization results in a less pronounced effect of BTX-A treatment. Children with cerebral palsy (CP) present altered gait patterns and e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gait & posture 2020-10, Vol.82, p.54-60
Hauptverfasser: Wesseling, M., Kainz, H., Hoekstra, T., Van Rossom, S., Desloovere, K., De Groote, F., Jonkers, I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 60
container_issue
container_start_page 54
container_title Gait & posture
container_volume 82
creator Wesseling, M.
Kainz, H.
Hoekstra, T.
Van Rossom, S.
Desloovere, K.
De Groote, F.
Jonkers, I.
description •BTX-A injections improve gait kinematics and kinetics in CP children.•BTX-A treatment has a limited effect on the muscle balance in CP children.•EMG-constrained optimization results in a less pronounced effect of BTX-A treatment. Children with cerebral palsy (CP) present altered gait patterns and electromyography (EMG) activity compared to typically developing children. To temporarily reduce muscular activity and to correct the abnormal muscle force balance, Botulinum Toxin type A (BTX-A) injections are used. What is the effect of BTX-A injections on dynamic muscle forces during gait, when calculated using an EMG-constrained approach?. Retrospective data of ten typically developing (TD) and fourteen children with spastic diplegic CP were used for musculoskeletal modeling and dynamic simulations of gait, before and after BTX-A treatment. Individual muscle forces were calculated using an EMG-constrained optimization, in which EMG of eight muscles was used as muscle excitation signal to constrain the muscle activation patterns. Paired t-tests were used to compare average modelled muscle forces in different phases of the gait cycle pre- and post-BTX-A, summarized in the muscle profile score. Two-sample t-tests were used to determine significant differences between TD and pre- and post-BTX-A modelled muscle forces. For most muscles, the force was decreased in CP compared to TD children in all phases of the gait cycle, both before and after BTX-A treatment. Differences in muscle forces before and after BTX-A treatment were limited, with only few significant differences between pre- and post-BTX-A. Compared to a standard static optimization approach, imposing the EMG activity increased modelled muscle forces for most muscles. Our findings indicate that BTX-A treatment has a limited effect on the muscle balance in CP children. Besides that, the use of EMG-constrained optimization is recommended when studying muscle balance in children with CP.
doi_str_mv 10.1016/j.gaitpost.2020.08.122
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2440665717</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0966636220305130</els_id><sourcerecordid>2440665717</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-17519e7bd98ca6aab3c56264421e03448f8d24b4ddae3666a9c8a60f19c25b803</originalsourceid><addsrcrecordid>eNqFkEtPLCEQhYnR6Pj4C4alm26BZmh6d6_GV2LiRteEhmplQsMI3Vfn38tk9G5dnaRyTp2qD6FzSmpKqLhc1a_aTeuYp5oRRmoia8rYHlpQ2XYVY7TbRwvSCVGJRrAjdJzzihDCG8kO0VHDZMfKngUKV3GavQvziKf46QJ2YQVmcjFkPLrgRu39ButhKEM8Rgveg8XjnI0HPMRkIGM7Jxde8fagEsfmzXmbIOAPN71hAwn6pD1ea583p-hgKApn33qCXm5vnq_vq8enu4frv4-V4VRMFW2XtIO2t500WmjdN2YpmOCcUSAN53KQlvGeW6uhEULozkgtyEA7w5a9JM0JutjtXaf4PkOe1OiyKcfrAHHOinFOhFi2tC1WsbOaFHNOMKh1Km-njaJEbVmrlfphrbasFZGqsC7B8--OuR_B_o_9wC2GPzsDlE__OUgqGwfBgHWp4FQ2ut86vgCvupXE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2440665717</pqid></control><display><type>article</type><title>Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy</title><source>MEDLINE</source><source>ScienceDirect</source><creator>Wesseling, M. ; Kainz, H. ; Hoekstra, T. ; Van Rossom, S. ; Desloovere, K. ; De Groote, F. ; Jonkers, I.</creator><creatorcontrib>Wesseling, M. ; Kainz, H. ; Hoekstra, T. ; Van Rossom, S. ; Desloovere, K. ; De Groote, F. ; Jonkers, I.</creatorcontrib><description>•BTX-A injections improve gait kinematics and kinetics in CP children.•BTX-A treatment has a limited effect on the muscle balance in CP children.•EMG-constrained optimization results in a less pronounced effect of BTX-A treatment. Children with cerebral palsy (CP) present altered gait patterns and electromyography (EMG) activity compared to typically developing children. To temporarily reduce muscular activity and to correct the abnormal muscle force balance, Botulinum Toxin type A (BTX-A) injections are used. What is the effect of BTX-A injections on dynamic muscle forces during gait, when calculated using an EMG-constrained approach?. Retrospective data of ten typically developing (TD) and fourteen children with spastic diplegic CP were used for musculoskeletal modeling and dynamic simulations of gait, before and after BTX-A treatment. Individual muscle forces were calculated using an EMG-constrained optimization, in which EMG of eight muscles was used as muscle excitation signal to constrain the muscle activation patterns. Paired t-tests were used to compare average modelled muscle forces in different phases of the gait cycle pre- and post-BTX-A, summarized in the muscle profile score. Two-sample t-tests were used to determine significant differences between TD and pre- and post-BTX-A modelled muscle forces. For most muscles, the force was decreased in CP compared to TD children in all phases of the gait cycle, both before and after BTX-A treatment. Differences in muscle forces before and after BTX-A treatment were limited, with only few significant differences between pre- and post-BTX-A. Compared to a standard static optimization approach, imposing the EMG activity increased modelled muscle forces for most muscles. Our findings indicate that BTX-A treatment has a limited effect on the muscle balance in CP children. Besides that, the use of EMG-constrained optimization is recommended when studying muscle balance in children with CP.</description><identifier>ISSN: 0966-6362</identifier><identifier>EISSN: 1879-2219</identifier><identifier>DOI: 10.1016/j.gaitpost.2020.08.122</identifier><identifier>PMID: 32892101</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Botulinum toxin type A injections ; Botulinum Toxins, Type A - pharmacology ; Botulinum Toxins, Type A - therapeutic use ; Cerebral palsy ; Cerebral Palsy - drug therapy ; Child ; EMG-constrained optimization ; Female ; Gait - physiology ; Humans ; Male ; Musculoskeletal modelling ; Neuromuscular Agents - pharmacology ; Neuromuscular Agents - therapeutic use ; Retrospective Studies</subject><ispartof>Gait &amp; posture, 2020-10, Vol.82, p.54-60</ispartof><rights>2020 The Author(s)</rights><rights>Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-17519e7bd98ca6aab3c56264421e03448f8d24b4ddae3666a9c8a60f19c25b803</citedby><cites>FETCH-LOGICAL-c416t-17519e7bd98ca6aab3c56264421e03448f8d24b4ddae3666a9c8a60f19c25b803</cites><orcidid>0000-0002-4255-8673</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.gaitpost.2020.08.122$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32892101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wesseling, M.</creatorcontrib><creatorcontrib>Kainz, H.</creatorcontrib><creatorcontrib>Hoekstra, T.</creatorcontrib><creatorcontrib>Van Rossom, S.</creatorcontrib><creatorcontrib>Desloovere, K.</creatorcontrib><creatorcontrib>De Groote, F.</creatorcontrib><creatorcontrib>Jonkers, I.</creatorcontrib><title>Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy</title><title>Gait &amp; posture</title><addtitle>Gait Posture</addtitle><description>•BTX-A injections improve gait kinematics and kinetics in CP children.•BTX-A treatment has a limited effect on the muscle balance in CP children.•EMG-constrained optimization results in a less pronounced effect of BTX-A treatment. Children with cerebral palsy (CP) present altered gait patterns and electromyography (EMG) activity compared to typically developing children. To temporarily reduce muscular activity and to correct the abnormal muscle force balance, Botulinum Toxin type A (BTX-A) injections are used. What is the effect of BTX-A injections on dynamic muscle forces during gait, when calculated using an EMG-constrained approach?. Retrospective data of ten typically developing (TD) and fourteen children with spastic diplegic CP were used for musculoskeletal modeling and dynamic simulations of gait, before and after BTX-A treatment. Individual muscle forces were calculated using an EMG-constrained optimization, in which EMG of eight muscles was used as muscle excitation signal to constrain the muscle activation patterns. Paired t-tests were used to compare average modelled muscle forces in different phases of the gait cycle pre- and post-BTX-A, summarized in the muscle profile score. Two-sample t-tests were used to determine significant differences between TD and pre- and post-BTX-A modelled muscle forces. For most muscles, the force was decreased in CP compared to TD children in all phases of the gait cycle, both before and after BTX-A treatment. Differences in muscle forces before and after BTX-A treatment were limited, with only few significant differences between pre- and post-BTX-A. Compared to a standard static optimization approach, imposing the EMG activity increased modelled muscle forces for most muscles. Our findings indicate that BTX-A treatment has a limited effect on the muscle balance in CP children. Besides that, the use of EMG-constrained optimization is recommended when studying muscle balance in children with CP.</description><subject>Botulinum toxin type A injections</subject><subject>Botulinum Toxins, Type A - pharmacology</subject><subject>Botulinum Toxins, Type A - therapeutic use</subject><subject>Cerebral palsy</subject><subject>Cerebral Palsy - drug therapy</subject><subject>Child</subject><subject>EMG-constrained optimization</subject><subject>Female</subject><subject>Gait - physiology</subject><subject>Humans</subject><subject>Male</subject><subject>Musculoskeletal modelling</subject><subject>Neuromuscular Agents - pharmacology</subject><subject>Neuromuscular Agents - therapeutic use</subject><subject>Retrospective Studies</subject><issn>0966-6362</issn><issn>1879-2219</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtPLCEQhYnR6Pj4C4alm26BZmh6d6_GV2LiRteEhmplQsMI3Vfn38tk9G5dnaRyTp2qD6FzSmpKqLhc1a_aTeuYp5oRRmoia8rYHlpQ2XYVY7TbRwvSCVGJRrAjdJzzihDCG8kO0VHDZMfKngUKV3GavQvziKf46QJ2YQVmcjFkPLrgRu39ButhKEM8Rgveg8XjnI0HPMRkIGM7Jxde8fagEsfmzXmbIOAPN71hAwn6pD1ea583p-hgKApn33qCXm5vnq_vq8enu4frv4-V4VRMFW2XtIO2t500WmjdN2YpmOCcUSAN53KQlvGeW6uhEULozkgtyEA7w5a9JM0JutjtXaf4PkOe1OiyKcfrAHHOinFOhFi2tC1WsbOaFHNOMKh1Km-njaJEbVmrlfphrbasFZGqsC7B8--OuR_B_o_9wC2GPzsDlE__OUgqGwfBgHWp4FQ2ut86vgCvupXE</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Wesseling, M.</creator><creator>Kainz, H.</creator><creator>Hoekstra, T.</creator><creator>Van Rossom, S.</creator><creator>Desloovere, K.</creator><creator>De Groote, F.</creator><creator>Jonkers, I.</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4255-8673</orcidid></search><sort><creationdate>202010</creationdate><title>Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy</title><author>Wesseling, M. ; Kainz, H. ; Hoekstra, T. ; Van Rossom, S. ; Desloovere, K. ; De Groote, F. ; Jonkers, I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-17519e7bd98ca6aab3c56264421e03448f8d24b4ddae3666a9c8a60f19c25b803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Botulinum toxin type A injections</topic><topic>Botulinum Toxins, Type A - pharmacology</topic><topic>Botulinum Toxins, Type A - therapeutic use</topic><topic>Cerebral palsy</topic><topic>Cerebral Palsy - drug therapy</topic><topic>Child</topic><topic>EMG-constrained optimization</topic><topic>Female</topic><topic>Gait - physiology</topic><topic>Humans</topic><topic>Male</topic><topic>Musculoskeletal modelling</topic><topic>Neuromuscular Agents - pharmacology</topic><topic>Neuromuscular Agents - therapeutic use</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wesseling, M.</creatorcontrib><creatorcontrib>Kainz, H.</creatorcontrib><creatorcontrib>Hoekstra, T.</creatorcontrib><creatorcontrib>Van Rossom, S.</creatorcontrib><creatorcontrib>Desloovere, K.</creatorcontrib><creatorcontrib>De Groote, F.</creatorcontrib><creatorcontrib>Jonkers, I.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gait &amp; posture</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wesseling, M.</au><au>Kainz, H.</au><au>Hoekstra, T.</au><au>Van Rossom, S.</au><au>Desloovere, K.</au><au>De Groote, F.</au><au>Jonkers, I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy</atitle><jtitle>Gait &amp; posture</jtitle><addtitle>Gait Posture</addtitle><date>2020-10</date><risdate>2020</risdate><volume>82</volume><spage>54</spage><epage>60</epage><pages>54-60</pages><issn>0966-6362</issn><eissn>1879-2219</eissn><abstract>•BTX-A injections improve gait kinematics and kinetics in CP children.•BTX-A treatment has a limited effect on the muscle balance in CP children.•EMG-constrained optimization results in a less pronounced effect of BTX-A treatment. Children with cerebral palsy (CP) present altered gait patterns and electromyography (EMG) activity compared to typically developing children. To temporarily reduce muscular activity and to correct the abnormal muscle force balance, Botulinum Toxin type A (BTX-A) injections are used. What is the effect of BTX-A injections on dynamic muscle forces during gait, when calculated using an EMG-constrained approach?. Retrospective data of ten typically developing (TD) and fourteen children with spastic diplegic CP were used for musculoskeletal modeling and dynamic simulations of gait, before and after BTX-A treatment. Individual muscle forces were calculated using an EMG-constrained optimization, in which EMG of eight muscles was used as muscle excitation signal to constrain the muscle activation patterns. Paired t-tests were used to compare average modelled muscle forces in different phases of the gait cycle pre- and post-BTX-A, summarized in the muscle profile score. Two-sample t-tests were used to determine significant differences between TD and pre- and post-BTX-A modelled muscle forces. For most muscles, the force was decreased in CP compared to TD children in all phases of the gait cycle, both before and after BTX-A treatment. Differences in muscle forces before and after BTX-A treatment were limited, with only few significant differences between pre- and post-BTX-A. Compared to a standard static optimization approach, imposing the EMG activity increased modelled muscle forces for most muscles. Our findings indicate that BTX-A treatment has a limited effect on the muscle balance in CP children. Besides that, the use of EMG-constrained optimization is recommended when studying muscle balance in children with CP.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>32892101</pmid><doi>10.1016/j.gaitpost.2020.08.122</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-4255-8673</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0966-6362
ispartof Gait & posture, 2020-10, Vol.82, p.54-60
issn 0966-6362
1879-2219
language eng
recordid cdi_proquest_miscellaneous_2440665717
source MEDLINE; ScienceDirect
subjects Botulinum toxin type A injections
Botulinum Toxins, Type A - pharmacology
Botulinum Toxins, Type A - therapeutic use
Cerebral palsy
Cerebral Palsy - drug therapy
Child
EMG-constrained optimization
Female
Gait - physiology
Humans
Male
Musculoskeletal modelling
Neuromuscular Agents - pharmacology
Neuromuscular Agents - therapeutic use
Retrospective Studies
title Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A39%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Botulinum%20toxin%20injections%20minimally%20affect%20modelled%20muscle%20forces%20during%20gait%20in%20children%20with%20cerebral%20palsy&rft.jtitle=Gait%20&%20posture&rft.au=Wesseling,%20M.&rft.date=2020-10&rft.volume=82&rft.spage=54&rft.epage=60&rft.pages=54-60&rft.issn=0966-6362&rft.eissn=1879-2219&rft_id=info:doi/10.1016/j.gaitpost.2020.08.122&rft_dat=%3Cproquest_cross%3E2440665717%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2440665717&rft_id=info:pmid/32892101&rft_els_id=S0966636220305130&rfr_iscdi=true